Xixiang Chen
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Exploring anti-SARS-CoV-2 natural products: dual-viral target inhibition by delphinidin and the anti-coronaviral efficacy of deapio platycodin D.
Journal: Natural products and bioprospecting
Published: March 25, 2025
Identifying Exifone as a Dual-Target Agent Targeting Both SARS-CoV-2 3CL Protease and the ACE2/S-RBD Interaction Among Clinical Polyphenolic Compounds.
Journal: International journal of molecular sciences
Published: February 05, 2025
Exploring bifunctional molecules for anti-SARS-CoV-2 and anti-inflammatory activity through structure-based virtual screening, SAR investigation, and biological evaluation.
Journal: International journal of biological macromolecules
Published: September 04, 2024
The Activation of Muscarinic Acetylcholine Receptors Protects against Neuroinflammation in a Mouse Model through Attenuating Microglial Inflammation.
Journal: International journal of molecular sciences
Published: August 30, 2024
Novel Alkynylamide-Based Nonpeptidic Allosteric Inhibitors for SARS-CoV-2 3-Chymotrypsin-like Protease.
Journal: ACS pharmacology & translational science
Published: June 18, 2024
Methyl rosmarinate is an allosteric inhibitor of SARS-CoV-2 3 CL protease as a potential candidate against SARS-cov-2 infection.
Journal: Antiviral research
Published: November 10, 2023
Danshensu inhibits SARS-CoV-2 by targeting its main protease as a specific covalent inhibitor and discovery of bifunctional compounds eliciting antiviral and anti-inflammatory activity.
Journal: International journal of biological macromolecules
Published: October 06, 2023
Ginkgolic acids inhibit SARS-CoV-2 and its variants by blocking the spike protein/ACE2 interplay.
Journal: International journal of biological macromolecules
Published: September 27, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026